NMNAT2 and peripheral neuropathy: A recent study illustrated that peripheral neuropathy caused by the chemotherapeutic agents vincristine and bortezomib is also triggered through axonal NMNAT2 depletion and that the consequent NAD+ loss is induced through SARM1 activation [133].